BSE filing, NSE: CHOLAFIN. Summary written from the filing by ALFA Finder's alert engine.
Cholamandalam Investment & Finance Company Ltd: key numbers
- Share price
- ₹1,545.20
- Market cap
- ₹1,30,295 Cr
- Revenue (annual)
- ₹31,073 Cr
- Net profit (annual)
- ₹5,233 Cr
- P/E (TTM)
- 20.9×Sector 19.7×
- Promoter holding
- 48.93%-0.29% QoQ
- FII holding
- 24.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cholamandalam Investment & Finance Company Ltd
All →Cholamandalam Investment & Finance Company Fund Raise
Cholamandalam's board approved a Qualified Institutions Placement fund raise on 28 October 2026, subject to shareholder postal ballot. The quantum, price and terms remain undetermined.
Cholamandalam Investment & Finance Company Earnings Call Transcript: Key Takeaways
Management reported strong growth across all segments, achieving an AUM of ₹2,42,630 Cr.
- Call
- Guides 23% growth
Cholamandalam Investment & Finance Company Investor Presentation: Key Takeaways
Q2 FY27 PAT ₹1,630 Cr (+41% YoY); disbursements +47% to ₹35,872 Cr; AUM ₹2,48,045 Cr (+25%); NIM 7.9%.
Cholamandalam Investment & Finance Company Q2 FY27 Results: Net Profit ₹1,630 Cr, Up 40.6% YoY
Cholamandalam Investment & Finance Company Ltd reported revenue from operations of ₹9,271 Cr (+23.8% YoY) and net profit of ₹1,630 Cr (+40.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,630 Cr · +40.6% YoY
Cholamandalam Investment & Finance Company Board Meeting Date
Cholamandalam Investment and Finance Company Ltd announced its Board will consider a proposal for capital raising via a qualified institutions placement on October 28, 2026.
Cholamandalam Investment & Finance Company Promoter Reclassification
Cholamandalam Investment and Finance Company Ltd reclassified Alagavista Greentech Private Limited from the promoter/promoter group to public shareholder category, effective 26 August, 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.